Key facts
- Notable investors include SOSV, IndieBio.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Flouv
- ·The full record, as it builds
Funding rounds
No funding rounds for Flouv are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Flouv
Developer of non-thermal fluid treatment systems designed for microbial inactivation and nutrient preservation. The company's platform utilizes UV-C technology with amalgam lamps and proprietary reactor designs to disinfect opaque and viscous liquids without heat, featuring helical flow paths, actinometric dose verification, and biodosimetry-based validation, enabling organizations to achieve pathogen reduction while maintaining product integrity, reducing energy consumption, and complying with regulatory standards.
- Sector
- Business Products and Services (B2B)
- HQ
- Albany, CA, United States
- Founded
- 2023
- Website
- flouv.us/
- Ownership
- Privately Held (backing)
Flouv doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Flouv shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Flouv in its N-PORT filings yet. We sweep new filings monthly.